Global Indomethacin Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Indomethacin market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Indomethacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Indomethacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Indomethacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Indomethacin include Xinhua Pharma, Merck, Ratiopharm, Ouyi Pharma, Konch Pharma and Hotai Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Indomethacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indomethacin.
The Indomethacin market size, estimations, and forecasts are provided in terms of sales volume (tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Indomethacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Indomethacin Segment by Company
Xinhua Pharma
Merck
Ratiopharm
Ouyi Pharma
Konch Pharma
Hotai Pharma
Indomethacin Segment by Type
Indomethacin Capsule
Indomethacin Tablet
Indomethacin Suppository
Others
Indomethacin Segment by Application
Children
Adults
Indomethacin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indomethacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Indomethacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indomethacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Indomethacin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Indomethacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Indomethacin market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Indomethacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Indomethacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Indomethacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Indomethacin include Xinhua Pharma, Merck, Ratiopharm, Ouyi Pharma, Konch Pharma and Hotai Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Indomethacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indomethacin.
The Indomethacin market size, estimations, and forecasts are provided in terms of sales volume (tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Indomethacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Indomethacin Segment by Company
Xinhua Pharma
Merck
Ratiopharm
Ouyi Pharma
Konch Pharma
Hotai Pharma
Indomethacin Segment by Type
Indomethacin Capsule
Indomethacin Tablet
Indomethacin Suppository
Others
Indomethacin Segment by Application
Children
Adults
Indomethacin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indomethacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Indomethacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indomethacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Indomethacin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Indomethacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
93 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Indomethacin Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Indomethacin Sales Estimates and Forecasts (2020-2031)
- 1.3 Indomethacin Market by Type
- 1.3.1 Indomethacin Capsule
- 1.3.2 Indomethacin Tablet
- 1.3.3 Indomethacin Suppository
- 1.3.4 Others
- 1.4 Global Indomethacin Market Size by Type
- 1.4.1 Global Indomethacin Market Size Overview by Type (2020-2031)
- 1.4.2 Global Indomethacin Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Indomethacin Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Indomethacin Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Indomethacin Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Indomethacin Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Indomethacin Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Indomethacin Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Indomethacin Industry Trends
- 2.2 Indomethacin Industry Drivers
- 2.3 Indomethacin Industry Opportunities and Challenges
- 2.4 Indomethacin Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Indomethacin Revenue (2020-2025)
- 3.2 Global Top Players by Indomethacin Sales (2020-2025)
- 3.3 Global Top Players by Indomethacin Price (2020-2025)
- 3.4 Global Indomethacin Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Indomethacin Major Company Production Sites & Headquarters
- 3.6 Global Indomethacin Company, Product Type & Application
- 3.7 Global Indomethacin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Indomethacin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Indomethacin Players Market Share by Revenue in 2024
- 3.8.3 2023 Indomethacin Tier 1, Tier 2, and Tier 3
- 4 Indomethacin Regional Status and Outlook
- 4.1 Global Indomethacin Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Indomethacin Historic Market Size by Region
- 4.2.1 Global Indomethacin Sales in Volume by Region (2020-2025)
- 4.2.2 Global Indomethacin Sales in Value by Region (2020-2025)
- 4.2.3 Global Indomethacin Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Indomethacin Forecasted Market Size by Region
- 4.3.1 Global Indomethacin Sales in Volume by Region (2026-2031)
- 4.3.2 Global Indomethacin Sales in Value by Region (2026-2031)
- 4.3.3 Global Indomethacin Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Indomethacin by Application
- 5.1 Indomethacin Market by Application
- 5.1.1 Children
- 5.1.2 Adults
- 5.2 Global Indomethacin Market Size by Application
- 5.2.1 Global Indomethacin Market Size Overview by Application (2020-2031)
- 5.2.2 Global Indomethacin Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Indomethacin Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Indomethacin Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Indomethacin Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Indomethacin Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Indomethacin Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Indomethacin Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Xinhua Pharma
- 6.1.1 Xinhua Pharma Comapny Information
- 6.1.2 Xinhua Pharma Business Overview
- 6.1.3 Xinhua Pharma Indomethacin Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Xinhua Pharma Indomethacin Product Portfolio
- 6.1.5 Xinhua Pharma Recent Developments
- 6.2 Merck
- 6.2.1 Merck Comapny Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Indomethacin Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Merck Indomethacin Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Ratiopharm
- 6.3.1 Ratiopharm Comapny Information
- 6.3.2 Ratiopharm Business Overview
- 6.3.3 Ratiopharm Indomethacin Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Ratiopharm Indomethacin Product Portfolio
- 6.3.5 Ratiopharm Recent Developments
- 6.4 Ouyi Pharma
- 6.4.1 Ouyi Pharma Comapny Information
- 6.4.2 Ouyi Pharma Business Overview
- 6.4.3 Ouyi Pharma Indomethacin Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Ouyi Pharma Indomethacin Product Portfolio
- 6.4.5 Ouyi Pharma Recent Developments
- 6.5 Konch Pharma
- 6.5.1 Konch Pharma Comapny Information
- 6.5.2 Konch Pharma Business Overview
- 6.5.3 Konch Pharma Indomethacin Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Konch Pharma Indomethacin Product Portfolio
- 6.5.5 Konch Pharma Recent Developments
- 6.6 Hotai Pharma
- 6.6.1 Hotai Pharma Comapny Information
- 6.6.2 Hotai Pharma Business Overview
- 6.6.3 Hotai Pharma Indomethacin Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Hotai Pharma Indomethacin Product Portfolio
- 6.6.5 Hotai Pharma Recent Developments
- 7 North America by Country
- 7.1 North America Indomethacin Sales by Country
- 7.1.1 North America Indomethacin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Indomethacin Sales by Country (2020-2025)
- 7.1.3 North America Indomethacin Sales Forecast by Country (2026-2031)
- 7.2 North America Indomethacin Market Size by Country
- 7.2.1 North America Indomethacin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Indomethacin Market Size by Country (2020-2025)
- 7.2.3 North America Indomethacin Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Indomethacin Sales by Country
- 8.1.1 Europe Indomethacin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Indomethacin Sales by Country (2020-2025)
- 8.1.3 Europe Indomethacin Sales Forecast by Country (2026-2031)
- 8.2 Europe Indomethacin Market Size by Country
- 8.2.1 Europe Indomethacin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Indomethacin Market Size by Country (2020-2025)
- 8.2.3 Europe Indomethacin Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Indomethacin Sales by Country
- 9.1.1 Asia-Pacific Indomethacin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Indomethacin Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Indomethacin Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Indomethacin Market Size by Country
- 9.2.1 Asia-Pacific Indomethacin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Indomethacin Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Indomethacin Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Indomethacin Sales by Country
- 10.1.1 South America Indomethacin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Indomethacin Sales by Country (2020-2025)
- 10.1.3 South America Indomethacin Sales Forecast by Country (2026-2031)
- 10.2 South America Indomethacin Market Size by Country
- 10.2.1 South America Indomethacin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Indomethacin Market Size by Country (2020-2025)
- 10.2.3 South America Indomethacin Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Indomethacin Sales by Country
- 11.1.1 Middle East and Africa Indomethacin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Indomethacin Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Indomethacin Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Indomethacin Market Size by Country
- 11.2.1 Middle East and Africa Indomethacin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Indomethacin Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Indomethacin Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Indomethacin Value Chain Analysis
- 12.1.1 Indomethacin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Indomethacin Production Mode & Process
- 12.2 Indomethacin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Indomethacin Distributors
- 12.2.3 Indomethacin Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


